牛皮中的TYK2和IL-23途径疗法:与IL-6的关联,三甲代谢和抑郁症状
Lanmei Lin1, Canbin Dong1, Gujie Wu2,3
1Department of Dermatology, Huashan Hospital Affiliated with Fudan University, Shanghai, China.
International journal of dermatology
|January 12, 2026
概括
氨酸激酶2 (TYK2) 抑制剂可以通过向炎症和情绪路径来治疗牛皮和抑郁症. 这项研究表明,TYK2抑制剂可以改善皮肤和心理健康症状.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 牛皮和抑郁症经常同时发生,由于它们的双向关系,使治疗复杂化.
- 这项研究调查了TYK2抑制剂在牛皮和并发性抑郁症中的双重治疗潜力.
研究的目的:
- 评估TYK2抑制剂在患有牛皮和抑郁症的患者中的疗效.
- 探索TYK2抑制剂潜在的双重作用背后的分子机制.
主要方法:
- 一组298名牛皮患者使用医院焦虑和抑郁量表 (HADS) 进行了评估.
- 患者被分为TYK2抑制剂,Janus激酶 (JAK) 抑制剂和非JAK治疗组.
- 统计分析使用了一般化的线性模型 (GENMOD),对临床共变量进行了调整.
主要成果:
- 与非JAK池相比,TYK2抑制剂的HADS-D得分明显较低.
- 转录组分析显示IL-6受体和抑郁路径的下调,与神经元活动路径的上调.
- 代谢分析显示氨酸水平降低,1H-英多尔-3-氨酸水平增加.
结论:
- TYK2 抑制剂可以通过向IL-23/Th17轴和IL-6/氨酸代谢来破坏"外周炎症-中心抑郁"循环.
- 这种多重目标的方法有潜力治疗伴随抑郁症的牛皮,改善皮肤和情绪症状.
- 这种创新的治疗策略的可能结果之一是改善患者的坚持治疗.
相关概念视频
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
The JAK-STAT Signaling Pathway
11.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.9K
Antidepressant Drugs: MAOIs and Other Agents
791
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
791
Depressive Disorders: Etiology
428
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
428
Depressive Disorders: MDD and Dysthymia
615
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
615
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.3K


